Medical Developments International Ltd
MVP
Company Profile
Business description
Medical Developments International Ltd is a specialized healthcare company. It manufactures and distributes the pharmaceutical drug and medical and veterinary equipment. The company provides a range of products in the areas of pain management, asthma, and resuscitation, plus veterinary equipment. It is organized into three business units: Pharmaceuticals, Medical Devices, and Veterinary products. Majority of its revenue comes from Pharmaceuticals Unit which engages in the sale of Penthrox within Australia, New Zealand, Europe the UK and some sales in Canada, the Middle East, Asia and South Africa.
Contact
4 Caribbean Drive
ScoresbyVIC3179
AUST: +61 395471888
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
30 June 2025
Employees
68
Medical Developments International Ltd News & Analysis
stocks
CSL remains favourite, but biotech field broadening
The biotech giant has jumped 22pc a year for the past decade but new players are emerging.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,410.70 | 94.00 | 1.13% |
| CAC 40 | 7,274.48 | 19.89 | -0.27% |
| DAX 40 | 19,884.75 | 85.11 | -0.43% |
| Dow JONES (US) | 42,840.26 | 498.02 | 1.18% |
| FTSE 100 | 8,084.61 | 20.71 | -0.26% |
| HKSE | 19,778.37 | 57.67 | 0.29% |
| NASDAQ | 19,572.60 | 199.83 | 1.03% |
| Nikkei 225 | 39,033.16 | 331.26 | 0.86% |
| NZX 50 Index | 12,912.94 | 8.83 | 0.07% |
| S&P 500 | 5,930.85 | 63.77 | 1.09% |
| S&P/ASX 200 | 8,159.70 | 92.70 | 1.15% |
| SSE Composite Index | 3,363.21 | 4.86 | -0.14% |